Myrica ER Tablet 330 mg contains Pregabalin in an extended-release (ER) formulation designed to provide sustained therapeutic effect over an extended period. Pregabalin is a well-established medication used for the management of neuropathic pain, certain seizure disorders, and fibromyalgia. The extended-release technology allows for controlled release of the active ingredient, helping maintain stable drug levels in the body and improving patient convenience with once-daily dosing.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Each extended-release tablet contains:
Pregabalin 330 mg
Pregabalin works by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. This action reduces the release of certain excitatory neurotransmitters such as glutamate, norepinephrine, and substance P. As a result, abnormal nerve signals responsible for pain and seizures are suppressed, leading to symptom relief.
Myrica ER Tablet 330 mg is indicated for:
Neuropathic pain associated with diabetic peripheral neuropathy
Postherpetic neuralgia (nerve pain following shingles)
Neuropathic pain due to spinal cord injury
Fibromyalgia
Adjunctive therapy for partial-onset seizures in adults
The extended-release formulation is particularly beneficial for patients requiring long-term pain management with simplified dosing.
Myrica ER Tablet 330 mg should be taken exactly as prescribed by a registered physician. It is usually administered once daily after an evening meal. The tablet must be swallowed whole with water and should not be crushed, chewed, or split, as this may interfere with the extended-release mechanism.
Dose adjustments may be necessary in patients with renal impairment. Sudden discontinuation should be avoided; the dose should be tapered gradually under medical supervision to prevent withdrawal symptoms.
Provides sustained pain relief with once-daily dosing
Helps reduce nerve-related burning, tingling, and shooting pain
Improves sleep disturbances associated with neuropathic pain
Enhances quality of life in patients with chronic pain conditions
Extended-release formulation ensures consistent drug levels
Common side effects may include:
Dizziness
Drowsiness
Dry mouth
Peripheral edema
Blurred vision
Weight gain
Most side effects are mild to moderate and tend to improve over time. Patients should consult their healthcare provider if symptoms persist or worsen.
Use with caution in patients with kidney impairment.
May cause dizziness and drowsiness; avoid driving or operating heavy machinery until the effect is known.
Not recommended during pregnancy or breastfeeding unless clearly advised by a physician.
Monitor for mood changes, depression, or suicidal thoughts.
Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.
Myrica ER Tablet 330 mg offers an effective and convenient option for managing chronic neuropathic pain and related conditions through its advanced extended-release formulation.
Login Or Registerto submit your questions to seller
No none asked to seller yet